Neurocognitive function in patients with β-thalassemia major

Pediatrics International

Volumn 53, Issue 4, 2011, Pages 519-523

  Duman, Ozgur ^a   Arayici, Sema ^b   Fettahoglu, Cigil ^c   Eryilmaz, Nurkan ^c   Ozkaynak, Sibel ^c   Yesilipek, Akif ^b   Hazar, Volkan ^b  

^a Department of Pediatric Neurology ^*  (Turkey)

^b AKDENIZ UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^c AKDENIZ UNIVERSITY   (Turkey)

Author keywords

thalassemia; anemia; cognition; mismatch negativity; P300

Indexed keywords

ADOLESCENT; ARTICLE; BETA THALASSEMIA; BRAIN FUNCTION; CHILD; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; EVENT RELATED POTENTIAL; FEMALE; HUMAN; INTELLIGENCE QUOTIENT; MALE; MEDICAL INSTRUMENTATION; MISMATCH NEGATIVITY; NEUROLOGICAL COMPLICATION; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL;

ADOLESCENT; AUDITORY PERCEPTUAL DISORDERS; BETA-THALASSEMIA; CASE-CONTROL STUDIES; CHILD; COGNITION; COGNITION DISORDERS; EVENT-RELATED POTENTIALS, P300; EVOKED POTENTIALS; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; INTELLIGENCE; MALE; NEUROPSYCHOLOGICAL TESTS; PERCEPTUAL DISORDERS; VISUAL PERCEPTION;

EID: 80051994823     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2010.03279.x     Document Type: Article

References (36)

1. Weatherall DJ,. Genomics and global health: Time for a reappraisal. Science 2003; 302: 597-9. (Pubitemid 37310905)
2. Weatherall DJ,. Keynote address: The challenge of thalassemia for the developing countries. Ann. N. Y. Acad. Sci. 2005; 1054: 11-17. (Pubitemid 43031005)
3. Borgna-Pignatti C, Cappellini MD, De Stefano P, et al,. Survival and complications in thalassemia. Ann. N. Y. Acad. Sci. 2005; 1054: 40-47. (Pubitemid 43031009)
4. Taher A, Isma'eel H, Mehio G, et al,. Prevalence of thromboembolic events among 8,860 patients with thalassemia major and intermedia in the Mediterranean area and Iran. Thromb. Haemost. 2006; 96: 488-91. (Pubitemid 44560684)
5. Cohen A, Martin M, Mizanin J, Konkle DF, Schwartz E,. Vision and hearing during deferoxamine therapy. J. Pediatr. 1990; 117: 326-30. (Pubitemid 20238555)
6. Wong V, Li A, Lee AC,. Neurophysiologic study of beta-thalassemia patients. J. Child Neurol. 1993; 8: 330-35.
7. Chen SH, Liang DC, Lin HC, Cheng SY, Chen LJ, Liu HC,. Auditory and visual toxicity during deferoxamine therapy in transfusion-dependent patients. J. Pediatr. Hematol. Oncol. 2005; 27: 651-3.
8. Incorpora G, Di Gregorio F, Romeo MA, Pavone P, Trifiletti RR, Parano E,. Focal neurological deficits in children with beta-thalassemia major. Neuropediatrics 1999; 30: 45-8. (Pubitemid 29161096)
9. Zafeiriou DI, Economou M, Athanasiou-Metaxa M,. Neurological complications in beta-thalassemia. Brain Dev. 2006; 28: 477-81.
10. Bandhu R, Shankar N, Tandon OP, Madan N,. Effects of iron therapy on cognition in anemic school going boys. Indian J. Physiol. Pharmacol. 2003; 47: 301-10. (Pubitemid 36876583)
11. Weiskopf RB, Toy P, Hopf HW, et al,. Acute isovolemic anemia impairs central processing as determined by P300 latency. Clin. Neurophysiol. 2005; 116: 1028-32.
12. Agaoglu L, Torun O, Unuvar E, Sefil Y, Demir D,. Effects of iron deficiency anemia on cognitive functions in children. Arzneimittelforschung 2007; 57: 426-30. (Pubitemid 47055993)
13. Nevruz O, Ulas U, Cetin T, Kutukcu Y, Kurekci A,. Cognitive dysfunction in β-thalassemia minor. Am. J. Hematol. 2007; 82: 203-7.
14. Naatanen R, Gaillard AW, Mantysalo S,. Early selective-attention effect on evoked potential reinterpreted. Acta Psychol. (Amst) 1978; 42: 313-29.
15. Heinze HJ, Münte TF, Kutas M, et al,. Cognitive event-related potentials. The International Federation of Clinical Neurophysiology. Electroencephalogr. Clin. Neurophysiol. Suppl. 1999; 52: 91-5.
16. Orsini A, Soulayrol R, Tramini F, Tasso-Perrimond AM,. Nervous manifestations associated with thalassemia (critical study of the concept of thalassemic neurohemolytic syndrome). Pediatrie 1967; 22: 771-84 (in French).
17. Logothetis J, Constantoulakis M, Economidou J, et al,. Thalassemia major (homozygous beta-thalassemia). A survey of 138 cases with emphasis on neurologic and muscular aspects. Neurology 1972; 22: 294-304.
18. Monastero R, Monastero G, Ciaccio C, Padovani A, Camarda R,. Cognitive deficits in beta-thalassemia major. Acta Neurol. Scand. 2000; 102: 162-8. (Pubitemid 30645134)
19. Zafeiriou DI, Kousi AA, Tsantali CT, et al,. Neurophysiological evaluation of long-term desferrioxamine therapy in beta-thalassemia patients. Pediatr. Neurol. 1998; 18: 420-24. (Pubitemid 28308710)
20. Triantafyllou NI, Anthracopoulos M, Zalonis I, et al,. Cognition in homozygous beta-thalassemia disease: A multichannel auditory event-related potential (P300) study. Electromyogr. Clin. Neurophysiol. 1992; 32: 531-5.
21. Kovacs M,. The Children's Depression Inventory (CDI). Psychopharmacol. Bull. 1985; 21: 995-8.
22. Oy B,. Çocuklar için Depresyon Ölçeǧi geçerlik ve güvenirlik çalişmasi. Türk. Psikiyatri. Dergisi. 1991; 2: 137-40.
23. Spielberg CD,. Preliminary Manual of State-Trait Anxiety Inventory for Children. Consulting Psychologists Pres, Palo Alto, 1973.
24. Özusta Ş,. Çocuklar için durumluluk sürekli kaygi envanteri'nin uyarlamasi, geçerlik ve güvenirlik çalişmasi. Yayinlanmamis Doktora Tezi. HÜ Sosyal Bilimler Enstitüsü, Ankara, 1993 (in Turkish).
25. Wechsler D, ed. Manual for the Wechsler Intelligence Scale for Children-Revised. Psychological Corporation, New York, 1974.
26. Türk Psikologlar Derneǧi. WISC-R. Türk Psikologlar Derneǧi Yayinlari, Ankara, 1994 (in Turkish).
27. Koppitz EM,. The Bender Gestalt test for children: A normative study. J. Clin. Psychol. 1960; 16: 432-5.
28. Yalin A,. Epileptik Cocuklarin Tanisinda Bender Gestalt Testinin Kullanimi. Yayinlanmamis Doktora Tezi. Hacettepe Universitesi Psikoloji Bölümü, Ankara, 1980 (in Turkish).
29. Metafratzi A, Argyropoulou MI, Kiortsis DN, Tsampoulas C, Chaliassos N, Efremidis SC,. T(2) relaxation rate of basal ganglia and cortex in patients with beta-thalassaemia major. Br. J. Radiol. 2001; 74: 407-10. (Pubitemid 32586545)
30. Manfrè L, Giarratano E, Maggio A, Banco A, Vaccaro G, Lagalla R,. MR imaging of the brain: Findings in asymptomatic patients with thalassemia intermedia and sickle cell-thalassemia disease. Am. J. Roentgenol. 1999; 173: 1477-80.
31. Eldor A, Rachmilewitz EA,. The hypercoagulable state in thalassemia. Blood 2002; 99: 36-43.
32. Marciani MG, Cianciulli P, Stefani N, et al,. Toxic effects of high-dose deferoxamine treatment in patients with iron overload: An electrophysiological study of cerebral and visual function. Haematologica 1991; 76: 131-4.
33. Economou M, Zafeiriou DI, Kontopoulos E, et al,. Neurophysiologic and intellectual evaluation of beta-thalassemia patients. Brain Dev. 2006; 28: 14-18. (Pubitemid 43042432)
34. Oken BS,. Endogenous event-related potentials. In:, Chiappa KH, (ed.). Evoked Potentials in Clinical Medicine, 3rd edn. Lippincott-Raven Publishers, Philadelphia, 1997; 529-63.
35. Giardina PJ, Grady RW, Ehlers KH, et al,. Current therapy of Cooley's anemia. A decade of experience with subcutaneous desferrioxamine. Ann. N. Y. Acad. Sci. 1990; 612: 275-85.
36. Jensen PD, Jensen FT, Christensen T, Ellegard J,. Evaluation of transfusional iron overload before and during iron chelation by magnetic resonance imaging of the liver and determination of serum ferritin in adult nonthalassemic patients. Br. J. Haematol. 1995; 89: 880-89.